Journal of PeriAnesthesia Nursing
Volume 22, Issue 2 , Pages 108-124 , April 2007

Nursing Challenges in the Administration of Oral Antidepressant Medications in Gastric Bypass Patients

  • Meg Voelker, RN, MN

      Affiliations

    • Corresponding Author InformationAddress correspondence to Ms Meg Voelker, 8537 Zircon Dr, SW #69, Lakewood, WA 98498
    • ,
  • Terri G. Foster, MA, RPh

References 

  1. Centers for Disease Control and Prevention. Health, United States 2005. 2006;Available at: http://www.cdc.gov/nchs/hus.htm. Accessed June 22
  2. American Society for Bariatric Surgery. Brief history and summary of bariatric surgery. 2006;Available at: http://www.asbs.org/html/patients/bypass.html. Accessed June 23
  3. Bishop R. A philosophy of exhibitionism: Exploring media coverage of Al Roker’s and Carnie Wilson’s gastric bypass surgeries. J Commun Inquiry. 2005;29:119–140
  4. Smoot TM, Xu P, Hilsenrath P, et al. Gastric bypass surgery in the United States, 1998-2002. Am J Public Health. 2006;96:1187–1189
  5. Steinbrook R. Estimated number of bariatric operations performed in the United States, 1992-2003. N Engl J Med. 2004;350:1075–1079
  6. Livingston EH, Ko CY. Socioeconomic characteristics of the population eligible for obesity surgery. Surgery. 2004;135:288–296
  7. Bray GA. In: Office management of obesity. Philadelphia, PA: WB Saunders; 2004;p. 1–31Chapters 1 and 2
  8. Samartin S, Chandra R. Obesity, over nutrition and the immune system. Nutr Res. 2001;21:243–262
  9. Bray GA. An Atlas of Obesity and Weight Control (The Encyclopedia of Visual Medicine Series). New York, NY: The Parthenon Publishing Group; 2003;
  10. Covington C, Cybulski M, Davis T, et al. Kids on the move: Preventing obesity among urban children. Am J Nurs. 2001;101:73–82
  11. Onyike CU, Crum RM, Hochang BL, et al. Is obesity associated with major depression? (Results from the Third National Health and Nutrition Examination Survey). Am J Epidemiol. 2003;159:1139–1147
  12. Whitaker RC, Orzol SM. Obesity among US urban preschool children. Arch Pediatr Adolesc Med. 2006;160:578–584
  13. Goodman E, Whitaker RC. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics. 2002;110:497–504Updated information available at: http://www.pediatrics.org/cgi/content/full/110/3/497. Accessed June 26, 2006
  14. Dixon JB, Dixon ME, O’Brien PE. Depression in association with severe obesity. Arch Intern Med. 2003;163:2058–2065
  15. Richardson LP, Davis R, Poulton R, et al. A longitudinal evaluation of adolescent depression and adult obesity. Arch Pediatr Adolesc Med. 2003;157:739–745
  16. Roberts RE, Deleger S, Strawbridge WJ, et al. Prospective association between obesity and depression: Evidence from the Alameda County Study. Int J Obes. 2003;27:514–521
  17. Sarwer DB, Cohn BA, Gibbons LM, et al. Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates. Obes Surg. 2004;14:1148–1156
  18. Glinski J, Wetzler S, Goodman E. The psychology of gastric bypass surgery. Obes Surg. 2001;11:581–588
  19. Powers PS, Rosemurgy A, Boyd F, et al. Outcome of gastric restriction procedures: Weight, psychiatric diagnoses, and satisfaction. Obes Surg. 1997;7:471–477
  20. Wadden TA, Butryn ML, Sarwer DB, et al. Comparison of psychosocial status in treatment-seeking women with class III vs. class I-II obesity. Surg Obes Relat Dis. 2006;2:138–145
  21. Berkowitz RI, Fabricatore AN. Obesity, psychiatric status, and psychiatric medications. Psychiatr Clin North Am. 2005;28:39–54
  22. Sachez-Santos R, Del Barrio MJ, Gonzalez C, et al. Long-term health-related quality of life following gastric bypass: Influence of depression. Obes Surg. 2006;16:580–585
  23. Thayer KM, Bruce ML. Recognition and management of major depression. Nurse Pract. 2006;31:12–25
  24. Mariappan P, Ballantyne Z, N’Dow JM, et al. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults [abstract]. Cochrane Database Sys Rev. 2005;3:CD004742
  25. Moore ML, Eichner SF, Jones JR. Treating functional impairment of autism with selective serotonin-reuptake inhibitors [abstract]. Ann Pharmacother. 2004;38:1515–1519
  26. Moreland AJ, Makela EH. Selective serotonin-reuptake inhibitors in the treatment of premature ejaculation [abstract]. Ann Pharmacother. 2005;39:1296–1301
  27. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain [abstract]. Cochrane Database Sys Rev. 2005;3:CD005454
  28. Westanmo AD, Gayken J, Haight R. Duloxetine: A balanced and selective norepinephrine- and serotonin-reuptake inhibitor. Am J Health Sys Pharm. 2005;62:2481–2490
  29. Arroll B, Macgillivray MA, Ogston S. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: A meta-analysis. Ann Fam Med. 2005;3:449–454
  30. Huyse FJ, Touw DJ, Van Schijndel RS, et al. Psychotropic drugs and the perioperative period: A proposal for a guideline in elective surgery. Psychosomatics. 2006;47:8–22
  31. American Gastroenterological Association. Medical position statement: Short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124:1105–1110
  32. Freitas RA. Nanomedicine, Volume I: Basic Capabilities. Georgetown, TX: Landes Bioscience; 1999. Available at: http://www.nanomedicine.con/NMI/8.2.3.htm. Accessed June 23, 2006.
  33. Williams PL. Gray’s Anatomy, The Basis of Medicine and Surgery. 38th ed. London, United Kingdom: Pearson Professional Limited; 1995;
  34. Jones DB, Provost DA, DeMaria EJ, et al. Optimal management of the morbidly obese patient. Surg Endosc. 2004;18:1029–1037
  35. Severijnen R, Bayat N, Bakker H, et al. Enteral drug absorption in patients with short small bowel, a review. Clin Pharmacokinet. 2004;43:951–962
  36. Berdanier CD. Nutrition and hollow organs of the upper gastrointestinal tract. In: Handbook of Nutrition and Food. Boca Raton, FL: CRC Press; 2002;p. 1165–1244
  37. Carlin AM, Rao DS, Meslemani AM, et al. Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis. 2006;2:98–103
  38. Cominette C, Garrido AB, Cozzolino SMF. Zinc nutritional status of morbidly obese patients before and after roux-en-y gastric bypass: A preliminary report. Obes Surg. 2006;16:448–453
  39. Dias MCG, Ribeiro AG, Scabim VM, et al. Dietary intake of female bariatric patients after anti-obesity gastroplasty. Clinics. 2006;61:93–98
  40. Madan AK, Whitney SO, Tichansky DS, et al. Vitamin and trace mineral levels after laparoscopic gastric bypass. Obes Surg. 2006;16:603–606
  41. Skroubis G, Anesidis S, Kehagias I, et al. Roux-en-y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population: Prospective comparison of the efficacy and the incidence of metabolic deficiencies. Obes Surg. 2006;16:488–495
  42. Voelker M. Assessing quality of life in gastric bypass clients. J Perianesth Nurs. 2004;19:89–104
  43. Al-Fahad T, Ismael A, Soliman MO, et al. Very early onset of Wernicke’s encephalopathy after gastric bypass. Obes Surg. 2006;16:671–672
  44. Escalona A, Perez G, Leon F, et al. Wernicke’s encephalopathy after roux-en-y gastric bypass. Obes Surg. 2004;14:1135–1137
  45. Yu W. Small molecule drug metabolism. IonSource.com Monograph 0008. Celera Corporation; 2002. Available at: http://www.ionsource.com/tutorial/metabolism/drug. Accessed August 2, 2004.
  46. Schrefer S, Alexopoulos Y. Kraus’s Food, Nutrition, and Diet Therapy. Philadelphia, PA: WB Saunders; 2004;
  47. Seaman JS, Bowers SP, Dixon P, et al. Dissolution of common psychiatric medications in a roux-en-y gastric bypass model. Psychosomatics. 2005;46:250–253
  48. Fuller AK, Tingle D, Devane CL, et al. Haloperidol pharmacokinetics following gastric bypass surgery. J Clin Psychopharmacol. 1986;6:376–378
  49. Malone M. Altered drug disposition in obesity and after bariatric surgery. Nutr Clin Pract. 2003;18:131–135
  50. Yogaratnam D, Miller MA, Smith BS. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient. Crit Care Nurs Clin North Am. 2005;17:245–250
  51. Schatzberg AF, Nemeroff CB. Principles of pharmacokinetics and pharmacodynamics. In: The American Psychiatric Publishing Textbook of Psychopharmacology. 3rd ed. Arlington, VA: Publisher; 2004;p. 130–135
  52. Smith CD, Herkes SB, Behrns KE, et al. Gastric acid secretion and vitamin B12 absorption after vertical roux-en-y gastric bypass for morbid obesity. Ann Surg. 1993;218:91–96
  53. Rhoades RA, Tanner GA. In: Medical Physiology. London, United Kingdom: Little, Brown & Co; 1995;p. 25–29485-583
  54. Macgregor AMC, Boggs . Drug distribution in obesity and following bariatric surgery: A literature review. Obes Surg. 1996;6:17–27
  55. Sundbom M, Märdh E, Märdl S, et al. Reduction in serum pepsinogen I after roux-en-y gastric bypass. J Gastro Surg. 2003;7:529–535
  56. Angulo P. NAFLD, obesity and bariatric surgery. Gastroenterology. 2006;130:1848–1852
  57. Klein S, Mittendorfer B, Eagon JC, et al. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology. 2006;130:1564–1572
  58. Fussy SA. The skinny on gastric bypass, what pharmacists need to know. US Pharm. 2005;2:HS3-HS12. Available at: http://www.uspharmacist.com/index. Accessed July 5, 2006
  59. Byatt N, Lundquist R. Pharmacologic treatment of major depressive disorder. eMedicine’s Depression and Anxiety Newsletter. 2006;Available at: http://www.emedicine.com/email/depressionanxiety/depression1-2.htm. Accessed July 13
  60. Maffei FA, Connolly H. Toxicity, tricyclic antidepressant. 2006;Available at: http://www.emedicine.com/ped/topic2714.htm. Accessed July 16
  61. Perry P. Antidepressant dosing. Clinical Psychopharmacology Seminar (Created 1996). 2006;Available at: http://www.tu.edu/user_files/10/17.html. Accessed July 13
  62. Mann JJ. The medical management of depression. N Engl J Med. 2005;353:1819–1834
  63. Devlin MJ, Yanovski SZ, Wilson GT. Obesity: What mental health professionals need to know. Am J Psychiatr. 2000;157:854–866
  64. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112–1120
  65. Lacy CF, Armstrong LL, Goldman MP. Drug Information Handbook, A Comprehensive Resource for all Clinicians and Healthcare Professionals. 14th ed. Hudson, OH: Lexi-Comp; 2006;
  66. Scott SK, Rabito FA, Price PD, et al. Comorbidity among the morbidly obese: A comparative study of 2002 U.S. hospital patient discharges. Surg Obes Relat Dis. 2006;2:105–111

 The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the US Department of the Army or the Department or Department of Defense.No potential conflict of interest relevant to this column was reported.

PII: S1089-9472(06)00441-2

doi: 10.1016/j.jopan.2006.11.005

Journal of PeriAnesthesia Nursing
Volume 22, Issue 2 , Pages 108-124 , April 2007

Article Tools

* Image Usage & Resolution